Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy

Abstract

BACKGROUND AND PURPOSE:

Mitochondrial neurogastrointestinal encephalopathy is a rare disorder due to recessive mutations in the thymidine phosphorylase gene, encoding thymidine phosphorylase protein required for mitochondrial DNA replication. Clinical manifestations include gastrointestinal dysmotility and diffuse asymptomatic leukoencephalopathy. This study aimed to elucidate the mechanisms underlying brain leukoencephalopathy in patients with mitochondrial neurogastrointestinal encephalopathy by correlating multimodal neuroradiologic features to postmortem pathology.

MATERIALS AND METHODS:

Seven patients underwent brain MR imaging, including single-voxel proton MR spectroscopy and diffusion imaging. Absolute concentrations of metabolites calculated by acquiring unsuppressed water spectra at multiple TEs, along with diffusion metrics based on the tensor model, were compared with those of healthy controls using unpaired t tests in multiple white matters regions. Brain postmortem histologic, immunohistochemical, and molecular analyses were performed in 1 patient.

RESULTS:

All patients showed bilateral and nearly symmetric cerebral white matter hyperintensities on T2-weighted images, extending to the cerebellar white matter and brain stem in 4. White matter, N-acetylaspartate, creatine, and choline concentrations were significantly reduced compared with those in controls, with a prominent increase in the radial water diffusivity component. At postmortem examination, severe fibrosis of brain vessel smooth muscle was evident, along with mitochondrial DNA replication depletion in brain and vascular smooth-muscle and endothelial cells, without neuronal loss, myelin damage, or gliosis. Prominent periependymal cytochrome C oxidase deficiency was also observed.

CONCLUSIONS:

Vascular functional and histologic alterations account for leukoencephalopathy in mitochondrial neurogastrointestinal encephalopathy. Thymidine toxicity and mitochondrial DNA replication depletion may induce microangiopathy and blood-brain-barrier dysfunction, leading to increased water content in the white matter. Periependymal cytochrome C oxidase deficiency could explain prominent periventricular impairment.

Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare autosomal recessive disorder due to mutations in the TYMP¹ gene that result in thymidine phosphorylase deficiency. This causes toxic systemic elevation of thymidine and deoxyuridine levels, deoxynucleotide pool imbalance, and secondary mitochondrial DNA replication (mtDNA) abnormalities.^2–5

Disease onset, typically in young adulthood, is characterized by a slowly progressive multisystemic involvement, which includes ptosis, chronic progressive external ophthalmoplegia with mitochondrial myopathy, demyelinating neuropathy, hearing loss, and, most important, severe gastrointestinal dysmotility, leading to cachexia and diverticulosis of the small bowel.^3,6

Severe mtDNA depletion is the most striking molecular defect affecting several tissues (ie, smooth muscle of the gastrointestinal wall and vasculature [small vessels]), suggesting that microvascular dysfunction may play a role in the pathogenesis.^7,8 Although the skeletal muscle does not express thymidine phosphorylase, the toxic nucleoside accumulation results in a typical mitochondrial myopathy due to both depletion and accumulation of multiple deletions of mtDNA.² Central nervous system involvement in MNGIE remains undercharacterized and puzzling. The brain neuroradiologic hallmark is leukoencephalopathy, with bilateral and symmetrically severe MR imaging signal alterations involving mostly cerebral hemispheric white matter.^9,10 Remarkably, despite the extensive MR imaging alterations, most patients with MNGIE remain asymptomatic⁶; brain proton MR spectroscopy (¹H-MR spectroscopy) studies of patients with MNGIE have shown white matter biochemical alterations suggesting either neuronal loss/dysfunction^11,12 or a normal metabolic profile.¹³ Furthermore, a previous study reported increased water diffusivity, evaluated by diffusion-weighted MR imaging, in 4 patients with MNGIE.¹² The neuropathologic study of 2 patients with genetically confirmed MNGIE did not show neuronal loss, demyelination, or glial proliferation, despite a striking loss of thymidine phosphorylase expression in capillaries of the white matter and an increased intracellular albumin staining, consistent with altered blood-brain barrier permeability.¹⁴

The purpose of this study was to elucidate the mechanisms underlying brain leukoencephalopathy in patients with MNGIE using a multimodal neuroradiologic and pathologic approach.

Materials and Methods

Patients

Seven unrelated patients with a molecular diagnosis of MNGIE (3 men; age range, 23–38 years) were included in this study.

Patients were scanned on a 1.5T MR imaging system (Signa Horizon LX; GE Healthcare, Milwaukee, Wisconsin). Quantitative MR imaging parameters were compared with those obtained from 9 healthy volunteers (4 men; age range, 20–35 years) who underwent white matter ¹H-MR spectroscopy and from 14 healthy volunteers (7 men; age range, 21–43 years) who underwent diffusion tensor imaging. Patients were clinically assessed by neurologic, gastroenterologic, and nutritional evaluations. Four patients died, and in 1 patient (case 7), a postmortem examination was performed.

The Ethics Committee of S.Orsola-Malpighi Hospital approved the study, and written informed consent was obtained.

Biochemical and Genetic Characterization

Thymidine phosphorylase activity was assessed and quantified as previously reported. The TYMP gene was Sanger-sequenced.¹⁵

Brain MR Imaging

Conventional Brain MR Imaging Protocol Acquisition.

Brain MR imaging was performed using a quadrature birdcage head coil. The conventional MR imaging protocol included an axial and coronal FLAIR T2 sequence, sagittal FSE T2, and axial FSE T1-weighted imaging.

Proton MR Spectroscopy Protocol Acquisition.

A volume of interest of 8 cm³ was selected in the left parieto-occipital white matter (PO-WM). Water-suppressed proton MR spectra were acquired using the point-resolved spectroscopy single-voxel localization sequence (PROBE) at TE = 35, 70, 100, 144, and 288 ms (TR = 4000 ms, number of acquisitions = 64) to estimate the T2 of N-acetylaspartate, creatine plus phosphocreatine, and choline-containing compounds¹⁶ for the group of healthy controls and for 3 of 7 patients.

For the remaining 4 patients, the left PO-WM spectrum was acquired only at TE = 35 ms to limit the acquisition time to 4 minutes 16 seconds. In all subjects, unsuppressed water spectra were also acquired at TE = 25, 30, 40, 50, 60, 80, 100, 300, 600, 900, and 1000 ms; with TR = 15,000 ms, as previously described,¹⁶ to evaluate the water signal and T2 water relaxation time.

Diffusion Tensor Imaging Protocol Acquisition.

DTI was performed by a single-shot echo-planar imaging sequence using 6 noncollinear directions of the diffusion gradients with the following parameters: TR = 10,000 ms, TE = 107 ms, slice thickness = 4 mm with a 2-mm gap, voxel size = 1.25 × 1.25 × 6 mm³, b-value = 900 s/mm².

Proton MR Spectroscopy Data Analysis.

Both suppressed and unsuppressed water spectra were processed with the fitting program LCModel (Version 6.3; http://www.lcmodel.com/).¹⁷ The exclusion criterion for ¹H-MR spectroscopy metabolite evaluation was an LCModel estimated fitting error of >20%. The absolute concentrations of NAA and Cho were obtained using the T2 times of the metabolites calculated by fitting the monoexponential decay of their signal in the water-suppressed PROBE spectra at different TEs¹⁸ and estimating the intracellular water content by the biexponential fit of water signal amplitude of the unsuppressed water spectra as detailed in the On-line Appendix. We considered a T2 relaxation value reported in the literature for mIns (150 ms)¹⁹ because TE values used for water-suppressed spectra acquisitions are not sufficiently short to obtain an accurate signal T2-decay of this metabolite.

Diffusion Tensor Imaging Data Analysis.

DTI processing was performed by using the FMRIB software library (FSL; http://www.fmrib.ox.ac.uk/fsl). DTI-EPI images were coregistered and corrected for eddy current and head movement effects using the FMRIB Linear Image Registration Tool (FLIRT; https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLIRT). Parameter maps for mean diffusivity (MD), fractional anisotropy (FA), axial diffusivity (AD, λ₁), and radial diffusivity [RD, (λ₂ + λ₃)/2] were determined voxelwise using the program DTIFit (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT/UserGuide#DTIFIT). The EPI images were registered to the T1-weighted images using FSL tools.

To correlate the DTI-derived parameters with the biochemical profile, we defined an ROI on the DTI using the spatial coordinates of the spectroscopy volume of interest localized in the left PO-WM. Because in this ROI, WM fibers do not have a single predominant orientation, additional ROIs were defined on MD map images within white matter regions with high fiber directionality to assess changes in AD and RD with greater accuracy, namely the optic radiations, the posterior limbs of the internal capsule (PLIC), and the splenium of the corpus callosum (On-line Fig 1). The mean values of MD, FA, AD, and RD were calculated for each ROI.

Statistical Analysis

We first evaluated differences in demographic data between patients and controls, using a t test or a Spearman χ² test as appropriate. We performed a t test for unpaired data to evaluate differences between patients and controls in quantitative MR imaging values, namely metabolite concentrations, water signals, T_{2brain water (BW)} and T_2CSF water relaxation times and DTI parameters. Moreover, in the patient group, we performed a Spearman test to evaluate the correlation between MR spectroscopy metabolite values and DTI parameters. The threshold for significance for all analyses was set at P < .05.

Postmortem Study

The postmortem study was performed in patient 7, eight months after the MR imaging. Whole-body postmortem examination was performed within 24 hours of death. The brain was removed and fixed in 4% buffered formalin for neuropathologic examination.

Histologic, Histochemical, and Immunohistochemical Analyses

Tissue specimens including frontal, temporal, parietal, occipital, insular, and cingulate cortices; basal ganglia; thalamus; hippocampus; amygdala, brain stem (midbrain, pons, medulla oblongata); and several blocks of cerebellar hemispheres, including the dentate nucleus, and vermis, were obtained from formalin-fixed brain tissue and used for histologic, histochemical, and immunohistochemical analyses. Six-micrometer-thick sections were stained with hematoxylin-eosin, periodic acid–Schiff, and periodic acid—Schiff plus diastase, Luxol fast blue, congo red, and PicroSirius Red. Immunohistochemical staining was performed using a large panel of antibodies (On-line Appendix).

Molecular Analysis on Postmortem Brain Samples

Paraffin brain sections from patient 7 and 3 age-matched controls (subjects who underwent postmortem examination for diagnostic purposes without clinical/pathologic evidence of central nervous system diseases) were subjected to laser capture microdissection with the MMI Nikon UV-CUT System (Molecular Machines & Industries, Glattbrug, Switzerland), as previously described²⁰ (also see the On-line Appendix).

Results

Genetic diagnosis and biochemical features of patients with MNGIE are reported in Table 1.

Table 1:

Demographic, genetic, and clinical features of patients with MNGIE

Case No.	Age at MRI (yr)/Sex	TYMP Mutationa	Mutation Type	TP Activity	Age at Neurologic Onset	Age at Gastroenterologicb Onset
1	23/F	c.1249 dupC	Frame shift	Undetectable	20 yr (ptosis/CPEO)	Childhood
2	29/F	c.1160–2A>G and c.1382_1383insC	Splice defect Frame shift	Undetectable	Childhood (CPEO)	Childhood
3	28/M	c.215–1G>A and c.328C>T	Splice defect p. Q110X	Undetectable	24 yr (ptosis/CPEO)	20 yr
4	27/F	c.1160–1G>A	Splice defect	Very low	20 yr (ptosis/CPEO)	Childhood
5	38/M	c.522T>A	Splice defect	Undetectable	37 yr (ptosis/CPEO)	30 yr
6	25/M	c.1160–1G>A	Splice defect	Very low	25 yr (peripheral neuropathy)	19 yr
7	36/M	c.457G>A	p. G153S	Undetectable	Childhood (ptosis)	25 yr

Note:—CPEO indicates chronic progressive external ophthalmoplegia; TP, thymidine phosphorylase.

^aAll homozygote.

^bMain gastroenterologic symptoms included irritable bowel and/or functional dyspepsia-like symptoms.

MR Imaging: Bilateral Altered White Matter Signal

Brain MR imaging revealed a bilateral and nearly symmetric white matter involvement characterized by hyperintensity on FLAIR T2 and FSE T2 and hypointensity on T1-weighted sequences in all patients (Fig 1, On-line Fig 2, and On-line Table). Mild-to-severe frontal and parieto-occipital white matter involvement was detected in each patient. The temporal lobe white matter and basal ganglia were affected in 5 patients, and the cerebellar white matter and brain stem, in 4. Three patients (cases 1, 2, and 3) with milder brain involvement showed signal intensity changes exclusively localized in the deep periventricular cerebral white matter with normal signal intensity of the infratentorial structures.

Fig 1.

MR imaging. Axial FLAIR T2 images from 2 of the 7 patients with MNGIE at the supra- and infratentorial levels. Case 1 does not show any infratentorial involvement, while a more diffuse supra- and infratentorial signal intensity increase can be seen in case 5.

¹H-MR Spectroscopy: Reduced Cerebral White Matter Metabolite Concentrations

In PO-WM, patients showed a significant decrease of NAA, Cr, and Cho concentrations. mIns, which had the highest metabolite variability in patients with MNGIE, showed a trend toward reduced concentration (Fig 2). Metabolite ratios such as NAA/Cr, Cho/Cr, and mIns/Cr were similar in patients and controls (Table 2).

Fig 2.

Proton MR spectroscopy. A, Axial FLAIR T2-weighted image shows the localization of the 8-cm^{3 1}H-MR spectroscopy volume of interest in the left parieto-occipital white matter in case 5. Proton MR spectra from the VOI in case 5 (B) and in a healthy control (C). The relative content of metabolites is similar in the patient and healthy subject. Note the higher level of noise in the patient and smaller metabolite peaks.

Table 2:

¹H-MRS white matter parieto-occipital metabolite absolute concentrations, ratios, and water signal intensity, and T2 values in patients with MNGIE and healthy controls

	Patients with MNGIE (n = 7) (mean ± SD)	Healthy Controls (n = 9) (mean ± SD)	P Valuea
Metabolite concentrations (mM)
NAA	6.98 ± 0.79	9.81 ± 0.94	<.001a,c
Cr	4.15 ± 0.48	5.97 ± 0.55	<.001a,c
Cho	1.53 ± 0.23	1.89 ± 0.24	.01a
mIns	4.46 ± 1.14	5.44 ± 0.76	.06a
Metabolite ratios
NAA/Cr	1.85 ± 0.18	1.80 ± 0.11	.57b
Cho/Cr	0.39 ± 0.06	0.33 ± 0.04	.04b
mIns/Cr	0.99 ± 0.27	0.85 ± 0.08	.16b
Water signal (a.u.)
SBW (0)	(14.0 ± 9.0)×1010	(10.8 ± 2.0)×1010	.370
SCSF (0)	(4.0 ± 7.5)×1010	(1.3 ± 0.6)×1010	.23a
T2 water
T2BW (ms)	112 ± 24	75 ± 8	.001a,c
T2CSF (ms)	520 ± 185	776 ± 344	.098a

Note:—a.u. indicates arbitrary units; S_BW (0) and S_CSF (0), water signals corresponding to brain and cerebrospinal water, respectively; T_2BW and T_2CSF, water relaxation times corresponding to brain and cerebrospinal water, respectively.

^aStatistical significance was set at P < .0125 after Bonferroni correction for multiple comparisons.

^bStatistical significance was set at P < .0167 after Bonferroni correction for multiple comparisons.

^cSignificant.

T_2BW values, calculated from the fast decay component of the signal from unsuppressed water acquisitions and attributable to both the intracellular and intramyelin water compartments, were significantly higher in patients compared with controls (Table 3 and On-line Fig 3).

Table 3:

DTI derivate metrics in patients with MNGIE and healthy controls

ROI	MD (Mean ± SD)	FA (Mean ± SD)	AD (Mean ± SD)	RD (Mean ± SD)
PO-WM
MNGIE	1.09 ± 0.16	0.27 ± 0.05	1.40 ± 0.16	0.93 ± 0.16
Controls	0.79 ± 0.05	0.40 ± 0.02	1.14 ± 0.07	0.61 ± 0.05
P Valuea	<.0001b	<.0001b	.0001b	<.0001b
OR
MNGIE	1.15 ± 0.20	0.41 ± 0.07	1.69 ± 0.19	0.88 ± 0.21
Controls	0.81 ± 0.05	0.59 ± 0.09	1.35 ± 0.12	0.54 ± 0.06
P Valuea	<.0001b	.0003b	.0002b	<.0001b
PLIC
MNGIE	0.78 ± 0.06	0.61 ± 0.07	1.40 ± 0.06	0.47 ± 0.08
Controls	0.69 ± 0.05	0.70 ± 0.04	1.36 ± 0.11	0.35 ± 0.05
P Valuea	.0019b	.0008b	0.36	.0003b
CC
MNGIE	0.88 ± 0.08	0.66 ± 0.06	1.64 ± 0.11	0.49 ± 0.10
Controls	0.81 ± 0.09	0.76 ± 0.06	1.72 ± 0.19	.35 ± 0.08
P Valuea	.12	.0012b	0.37	.0028b

Note:—OR indicates optic radiation; CC, corpus callosum.

^aStatistical significance was set at P < .003 after Bonferroni correction for multiple comparisons.

^bSignificant.

DTI: Prominent Increase of White Matter Radial Diffusivity

In the same PO-WM region selected for the MR spectroscopy acquisition, patients with MNGIE showed significantly higher MD, RD, and AD as well as significantly lower FA values compared with controls. The RD increase, relative to mean control values, was more prominent than the AD increase (RD, +52%; AD, +23%). Similar results were obtained in the optic radiations. In patients with MNGIE, the difference between RD and AD changes was even more evident in the PLIC and splenium of the corpus callosum, where a significant increase in RD values was associated with unchanged AD in both ROIs (Table 3).

Correlation analysis between metabolite concentrations and DTI metrics from the same PO-WM voxel in patients with MNGIE disclosed a negative correlation between NAA absolute concentration and MD (r = −0.82, P = .023), RD (r = −0.82, P = .02), and AD values (r = −0.89, P = .007).

Neuropathology: Fibrosis of Small-Vessel Walls and Microbleeding

Gross examination findings of the brain and vessels of the circle of Willis were unremarkable. Microscopic examination revealed a moderate pallor of the deep cerebral white matter extending focally into the internal capsule and thalamic white matter, while sparing the arcuate fibers and the corpus callosum. These changes, however, were not associated with a significant gliosis, neuronal loss, or axonal degeneration. The gray matter was also unremarkable.

The most striking feature was observed at the level of small perforating arterioles, which showed a replacement of smooth-muscle cells of the tunica media by dense fibrous tissue (Fig 3A–C). Loss of smooth-muscle cells was more evident in the external layers of the tunica media (Fig 3B), though a total fibrous replacement was observed in some vessels (Fig 3C). These features were particularly frequent in the white matter of the frontal lobe, the basal ganglia, and the midbrain, but absent in pial arteries (not shown). Fibrosis was occasionally associated with concentric wall thickening and luminal narrowing (Fig 3D). In addition, hemosiderin-laden macrophages, consistent with previous microbleeding aspects, were observed close to fibrotic small vessels and capillaries (Fig 3E). Immunohistochemical stains revealed increased deposition of collagen IV in the basal lamina of several vessels (not shown) and a slight perivascular gliosis (Fig 3F). The endothelial layer, as observed by CD31 immunostaining, was unremarkable (not shown). Immunostaining for amyloid was negative (not shown).

Fig 3.

Histologic features of brain vessels in patient 7 with MNGIE. A, Representative image of a penetrating arteriole showing increased collagen deposition in the tunica media (arrow) (H&E, original magnification ×40). B, Loss of smooth-muscle cells of the tunica media in a penetrating vessel, especially evident at the outermost layer (smooth-muscle actin, original magnification ×40). C, A thick fibrous coat completely replaces the 3-layer structure of a penetrating vessel (PicroSirius Red, original magnification ×40). D, Fibrous replacement is associated with luminal narrowing in a small brain vessel (PicroSirius Red, original magnification ×40). E, Perl iron stain consistent with hemosiderin deposits close to a brain capillary (Perls stain, original magnification ×40). F, Perivascular gliosis (glial fibrillary acidic protein, original magnification ×40).

Consistent with the mitochondrial etiology of the disease, scattered neurons showed decreased expression of the mtDNA-encoded COX I subunit. This feature was particularly evident in the subependymal region of the lateral ventricles (not shown) and was paralleled by mtDNA depletion in different regions of the brain (frontal gray and white matter, and substantia nigra) and, most important, in microdissected vascular smooth-muscle and endothelial cells (Fig 4).

Fig 4.

The mtDNA amount in the brain of patient 7 with MNGIE. A, mtDNA amount in smooth-muscle and endothelial cells microdissected by laser capture from an MNGIE brain and controls (n = 3) (expressed as mtDNA copy per nucleus). B, The mtDNA amount in different cerebral regions microdissected by laser capture from MNGIE and controls (n = 3) (expressed as mtDNA copy per nucleus). SN indicates substantia nigra; CTR, controls.

Discussion

We documented that leukoencephalopathy, the hallmark of brain MR imaging in MNGIE, is characterized by dilution of all metabolites associated with a prominent increase of the radial component of water diffusion in multiple white matter regions. These results, obtained in 7 patients, combined with the postmortem findings in the brain of one of them, support the hypothesis that neuroradiologic abnormalities in MNGIE result from microvascular damage. Indeed, we found a diffuse replacement of the vascular wall by dense fibrous tissue and multiple perivascular microbleeds in the white matter of the frontal lobe, in the basal ganglia, and in the midbrain.

Pathologic features of vessels are reminiscent of those described in cerebral microvessel disease^21–23 and point to impaired intracerebral blood flow regulation and blood-brain barrier permeability as synergic mechanisms leading to increased intracellular and intramyelin water content. The fibrosis of vascular smooth-muscle cells is in line with that observed in the external layer of the muscularis propria of the gastrointestinal tract,⁸ which is the main factor responsible for the severe dysmotility occurring in most patients with MNGIE. Analogous to observations in the muscularis propria and small vessels of the gastrointestinal wall, brain angiopathy is also characterized by a severe mtDNA depletion and COX deficiency, triggered by the toxic effects of high circulating levels of nucleosides.⁸ A previous brain neuropathologic study of 2 patients with MNGIE showed an increase of albumin immunoreactivity in the cytoplasm of reactive astrocytes compared with controls.¹⁴ This finding was interpreted as a result of a functional blood-brain barrier alteration, as suggested by the embryogenic role played by TYMP in glial proliferation.²⁴

In all our patients, brain MR imaging demonstrated a typical, diffuse (mild-to-severe) leukoencephalopathy, in striking contrast to the absence of clinical central nervous system involvement, as observed in previously reported patients.⁶ In particular, in mildly affected patients, MR imaging signal alterations were confined to the subependymal deep cerebral white matter, while in the severely affected patients, these changes extended to the subcortical white matter, deep gray matter, and subtentorial structures. This gradient of MR imaging white matter abnormalities parallels the prominent COX deficiency seen in case 7 in the periependymal tissue, which may be damaged first by high CSF levels of thymidine.

¹H-MR spectroscopy of the cerebral white matter of patients with MNGIE showed significant reductions of NAA, Cho, and Cr concentrations. The increase of the T2 of the water signals, derived from a slower decay of the unsuppressed water signal at a short TE (26–300 ms), may be attributed to both intramyelinic and intracellular water.²⁵ The significant increase in T2 of intracellular water of patients compared with controls suggests the enlargement of the intracellular compartment and consequently supports the hypothesis of a dilution effect underpinning the decreased metabolite concentrations. Previous ¹H-MR spectroscopy studies performed on 7 patients with MNGIE suggested unchanged metabolite ratios in the cerebral white matter.^11–13 For the first time, we provide absolute metabolite quantification by acquiring unsuppressed water spectra at multiple TEs, to distinguish intra- from extracellular water.¹⁸

In our patients with MNGIE, the DTI metrics in the same parieto-occipital voxel of the ¹H-MR spectroscopy study showed an increase of mean diffusivity and a decrease of fractional anisotropy values, with a more prominent involvement of the radial than longitudinal diffusivity. To better estimate variations in axial and radial diffusivity, considering the abundance of white matter crossing fibers in the parieto-occipital voxel, we also evaluated DTI metrics in WM tracts with high fiber directionality, such as the optic radiations, PLIC, and splenium of corpus callosum. In all these structures, a prominent increase of radial diffusivity was confirmed (Table 3). ROIs of the splenium of the corpus callosum and PLIC showed a selective increase in radial diffusivity with unchanged axial diffusivity. Radial diffusivity is considered a measure of myelin integrity,²⁶ as demonstrated by its selective increase in the corpus callosum of animal models with cuprizone-induced demyelination^27,28 and in the optic nerves of mice with demyelination resulting from retinal ischemia.²⁹ Similarly, in patients with relapsing-remitting multiple sclerosis, tract-specific DTI analysis of the optic radiations showed selective increases in RD only within the T2 lesions and, therefore, related to local myelin disruption.³⁰

The absence of demyelination at postmortem examination in one of our patients with MNGIE as well as in the other 2 previously reported cases¹⁴ points to increased intramyelin water content as the most likely explanation for prominent or selective radial diffusivity found in brain white matter structures in our patients. A negative correlation between N-acetylaspartate concentration and mean diffusivity values within the same white matter volume was demonstrated, supporting the hypothesis of a dilution effect as the basis of the metabolite concentration reduction, possibly affecting neuronal cells, because no correlation was observed between any other metabolite concentration expressed in either neural or glial cells and any DTI metrics.

In addition to fibrous replacement of the vascular wall, the neuropathologic study revealed multiple microbleeds in the white matter of the frontal lobe, basal ganglia, and midbrain. None of the MNGIE T2-weighted images revealed foci of local signal loss consistent with the presence of hemosiderin deposits,³¹ though sequences such as gradient-echo T2*-weighted susceptibility-weighted imaging, the most sensitive MR imaging for the detection of hemosiderin deposits,³² were not acquired. However, the neuroradiologic and clinical features characterizing small-vessel disease, such as lacunar strokes and progressive cognitive decline,³³ were absent in all our patients, suggesting key differences of small-vessel involvement in MNGIE compared with other conditions.

Conclusions

White matter metabolic and microstructural alterations detected in patients with MNGIE can be related to microangiopathy in the deep white matter and an energy metabolism deficit in the subependymal cells. Leukoencephalopathy in MNGIE may be the result of endothelial failure due to thymidine toxicity and mtDNA depletion, which may induce blood-brain barrier dysfunction and microangiopathy, leading to increased white matter water content. The question of whether leukoencephalopathy is a reversible feature cannot be solved at present. Long-term follow-up of patients with bone marrow^34,35 and liver transplantation³⁶ will likely provide an answer.

ABBREVIATIONS:

AD

axial diffusivity

BW

brain water

FA

fractional anisotropy

MNGIE

mitochondrial neurogastrointestinal encephalopathy

mtDNA

mitochondrial DNA replication

MD

mean diffusivity

PLIC

posterior limbs of the internal capsule

PO-WM

parieto-occipital white matter

RD

radial diffusivity